Bariatric surgery and left ventricular assist device in patients with heart failure: A systematic review and meta-analysis

Sharma, Ishna; Nakanishi, Hayato; Hage, Karl; Marrero, Katie; Diwan, Tayyab S.; Deabreu, Andrea; Davis, Scott; Clapp, Benjamin; Ghanem, Omar M.

doi:10.1016/j.amjsurg.2023.06.014

Cited by 8 publications

(3 citation statements)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Weight loss is recommended for this patient population before listing for cardiac transplantation [19]. Sleeve gastrectomy is thought to assist with weight loss and permit cardiac transplantation in patients with left ventricular assist devices (LVADs) [20,21]. Sharma et al evaluated the role and safety of metabolic surgery in heart failure patients with LVADs awaiting heart transplants.…”

Section: Sleeve Gastrectomy As a Bridge To Transplantmentioning

confidence: 99%

“…The most frequently reported complications were major adverse cardiovascular events (30.2%), followed by GI-related bleeding (20.9%) and LVAD pump thrombosis (11.6%). A total of 67 of the 271 patients (32.5%) received a heart transplant, with a mean time between bariatric surgery and heart transplant of 13.8 months [21]. Both LSG at the time of LVAD implantation and staged LSG following LVAD implantation have been reported [22].…”

Section: Sleeve Gastrectomy As a Bridge To Transplantmentioning

confidence: 99%

See 1 more Smart Citation

The Art of Sleeve Gastrectomy

Tish,

Corcelles

2024

JCM

View full text Add to dashboard Cite

Sleeve gastrectomy (SG) has historically evolved from gastroplasty and anti-reflux procedures into one of the most commonly performed primary metabolic surgeries in the United States and worldwide. Initially initiated in the 1980s as part of the duodenal switch procedure, its standalone effectiveness and simplicity have led to increasing popularity globally. The rise in obesity rates transcends age boundaries, alarmingly affecting not only adults but also the younger demographic. This escalating trend is concerning, as it predisposes these populations to numerous future health complications, as well as highlighting the critical necessity for a safe and potent weight loss strategy. Although sleeve gastrectomy carries a higher risk for gastroesophageal reflux disease (GERD) compared to other bariatric procedures, it stands out as a reliable, safe and effective surgical solution for obesity. It is particularly beneficial for adolescents and patients with complex medical comorbidities, including, but not limited to, heart failure and immunocompromisation. It has also served as a bridge for transplants in morbidly obese patients with end-stage heart, liver and kidney disease due to its favorable safety profile.

show abstract

Section: Sleeve Gastrectomy As a Bridge To Transplantmentioning

confidence: 99%

Section: Sleeve Gastrectomy As a Bridge To Transplantmentioning

confidence: 99%

The Art of Sleeve Gastrectomy

Tish,

Corcelles

2024

JCM

View full text Add to dashboard Cite

show abstract

“…1 To meet the demand of the obesity epidemic, the number of metabolic and bariatric surgery (MBS) has grown from 100092 per year in 2014 to 394431 in 2019. 2 Although MBS is known as the most effective approach to reaching weight loss and resolution of obesity-associated medical problems as well as showing a potential benefit in the management of selected cancers, [3][4][5] less than one percent of eligible patients undergo MBS in the United States. 6 In 1988, Hess et al initially proposed the biliopancreatic diversion with duodenal switch (BPD-DS) as a modification of Scopinaro's biliopancreatic diversion surgery.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Long-Term Nutrition Outcomes After Duodenal Switch: A Systematic Review and Meta-Analysis

Nakanishi,

Abi Mosleh,

AL-Kordi

et al. 2023

The American Surgeon™

Self Cite

View full text Add to dashboard Cite

Background Biliopancreatic diversion with duodenal switch (BPD-DS) is the most effective and durable metabolic and bariatric surgery to achieve a target weight loss. However, many surgeons are hesitant to adopt BPD-DS due to a lack of training, technical complexity, and long-term nutrition deficiencies. This meta-analysis aimed to investigate long-term nutrition outcomes after primary BPD-DS in the management of obesity. Methods Cochrane, Embase, PubMed, Scopus, and Web of Science were searched for articles from their inception to February 2023 by 2 independent reviewers using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) system. The review was registered prospectively with PROSPERO (CRD42023391316). Results From 834 studies screened, 8 studies met the eligibility criteria, with a total of 3443 patients with obesity undergoing primary BPD-DS. At long-term follow-up (≥5 years), 25.4% of patients had vitamin A deficiency (95% CI: -.012, .520, I2 = 94%), and 57.3% had vitamin D deficiency (95% CI: .059, 1.086, I2 = 86%). Calcium deficiency was observed in 125 patients (22.2%, 95% CI: .061, .383, I2 = 97%), and 69.7% had an abnormal parathyroid hormone level (95% CI: .548, .847, I2 = 78%). Ferritin level was abnormal in 30 patients (29.0%, 95% CI: .099, .481, I2 = 79%). Conclusions Despite displaying comparable nutrition-related outcomes to mid-term follow-up, our study demonstrated that BPD-DS could result in a high level of long-term nutrition deficiency after BPD-DS for selected patients. However, further randomized controlled studies with standardized supplementation regimens and improvement in compliance are necessary to evaluate and prevent long-term nutritional deficiencies after BPD-DS.

show abstract